Compound Detail
CHEMBL3358920
ETRASIMOD 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
O=C(O)C[C@H]1CCc2c1[nH]c1ccc(OCc3ccc(C4CCCC4)c(C(F)(F)F)c3)cc21
Basic Information
| ChEMBL ID | CHEMBL3358920 |
| Name | ETRASIMOD |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | MVGWUTBTXDYMND-QGZVFWFLSA-N |
| Therapeutic | ✓ Yes |
13
Targets
17
Activities
2
Assay Types
30
PK Parameters
20
Publications
4
Known Names
8
Indications
1
Mechanisms
Molecular Properties
457.5
MW (Da)
6.93
ALogP
2
HBA
2
HBD
62.3
PSA (Ų)
0.42
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2023 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Sphingosine 1-phosphate receptor Edg-1 agonist | AGONIST | Sphingosine 1-phosphate receptor 1 | ✓ | ✓ |
Indications
Colitis, Ulcerative Crohn Disease Alopecia Areata Dermatitis, Atopic Eosinophilic Esophagitis Inflammatory Bowel Diseases Liver Cirrhosis, Biliary Pyoderma
ATC Classification
L04AE05
etrasimod
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: IMMUNOSUPPRESSANTS
Activity Summary
EC50 11 meas. best 10.4
IC50 6 meas. best 8.73
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Sphingosine 1-phosphate receptor 1 CHEMBL4333 | EC50 | 10.4 | 9.2 | 0.0 | 4 |
| Sphingosine 1-phosphate receptor 1 CHEMBL1914263 | EC50 | 9.49 | 9.49 | 0.3 | 1 |
| Sphingosine 1-phosphate receptor 1 CHEMBL3559675 | EC50 | 9.49 | 9.49 | 0.3 | 1 |
| Sphingosine-1-phosphate receptor 1 CHEMBL3559680 | EC50 | 9.47 | 9.47 | 0.3 | 1 |
| Sphingosine 1-phosphate receptor 1 CHEMBL1914262 | EC50 | 9.36 | 9.36 | 0.4 | 1 |
| Sphingosine 1-phosphate receptor 1 CHEMBL4333 | IC50 | 8.73 | 8.73 | 1.9 | 1 |
| Sphingosine 1-phosphate receptor 5 CHEMBL2274 | EC50 | 7.61 | 7.61 | 24.4 | 1 |
| Unchecked CHEMBL612545 | EC50 | 7.52 | 7.52 | 29.9 | 1 |
| Rattus norvegicus CHEMBL376 | IC50 | 7.29 | 7.29 | 51.0 | 1 |
| Canis familiaris CHEMBL373 | IC50 | 7.24 | 7.24 | 58.0 | 1 |
| Rhesus monkey CHEMBL614875 | IC50 | 7.01 | 7.01 | 98.0 | 1 |
| Mus musculus CHEMBL375 | IC50 | 7.0 | 7.0 | 101.0 | 1 |
| Sphingosine 1-phosphate receptor 4 CHEMBL3230 | EC50 | 6.83 | 6.83 | 147.0 | 1 |
| Adenosine receptor A3 CHEMBL256 | IC50 | 5.48 | 5.48 | 3300.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 23100.0 | ng.hr.mL-1 | Macaca mulatta |
| AUC | 164000.0 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 3790.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 10300.0 | ng.hr.mL-1 | Mus musculus |
| CL | 2.23 | % | Macaca mulatta |
| CL | 0.746 | % | Canis lupus familiaris |
| CL | 3.45 | % | Rattus norvegicus |
| CL | 2.0 | % | Mus musculus |
| CL | 0.9467 | mL.min-1.kg-1 | Macaca mulatta |
| CL | 0.23 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 2.417 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 1.833 | mL.min-1.kg-1 | Mus musculus |
| Cmax | 182700.0 | nM | Rattus norvegicus |
| Cmax | 135700.0 | nM | Rattus norvegicus |
| Cmax | 6273.36 | nM | Macaca mulatta |
| Cmax | 8109.47 | nM | Canis lupus familiaris |
| Cmax | 476.51 | nM | Rattus norvegicus |
| Cmax | 1704.96 | nM | Mus musculus |
| Cmax | 789.09 | nM | Rattus norvegicus |
| F | 43.8 | % | Macaca mulatta |
| F | 73.2 | % | Canis lupus familiaris |
| F | 54.0 | % | Rattus norvegicus |
| F | 100.0 | % | Mus musculus |
| F | 54.0 | % | Rattus norvegicus |
| T1/2 | 6.37 | hr | Macaca mulatta |
| T1/2 | 28.8 | hr | Canis lupus familiaris |
| T1/2 | 9.64 | hr | Rattus norvegicus |
| T1/2 | 12.3 | hr | Mus musculus |
| T1/2 | 1.0 | hr | Macaca mulatta |
| T1/2 | 1.0 | hr | Canis lupus familiaris |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 25516790 | 10.1021/ml500389m | Rattus norvegicus | 25 |
| 25516790 | 10.1021/ml500389m | Canis familiaris | 13 |
| 25516790 | 10.1021/ml500389m | Mus musculus | 13 |
| 25516790 | 10.1021/ml500389m | Sphingosine 1-phosphate receptor 1 | 11 |
| 32223194 | 10.1021/acs.jmedchem.9b01663 | Mus musculus | 11 |
| - | 10.6019/CHEMBL4689842 | HEK-293T | 10 |
| - | 10.6019/CHEMBL4689842 | Fibroblast | 10 |
| - | 10.6019/CHEMBL4689842 | U2OS | 9 |
| 25516790 | 10.1021/ml500389m | Rhesus monkey | 9 |
| 37948883 | 10.1016/j.ejmech.2023.115921 | Staphylococcus aureus | 8 |
| 25516790 | 10.1021/ml500389m | Plasma | 3 |
| 37948883 | 10.1016/j.ejmech.2023.115921 | Erythrocyte | 3 |
| 25516790 | 10.1021/ml500389m | Liver microsome | 3 |
| - | 10.6019/CHEMBL5209801 | Alpha-2A adrenergic receptor | 2 |
| - | 10.6019/CHEMBL5209801 | Free fatty acid receptor 4 | 2 |
| - | 10.6019/CHEMBL5209801 | G-protein coupled receptor 35 | 2 |
| 25516790 | 10.1021/ml500389m | Salmonella typhimurium | 2 |
| 25516790 | 10.1021/ml500389m | ADMET | 2 |
| 25516790 | 10.1021/ml500389m | Sphingosine 1-phosphate receptor 4 | 2 |
| 25516790 | 10.1021/ml500389m | Voltage-gated inwardly rectifying potassium channel KCNH2 | 2 |
Data from ChEMBL 36 via Core Engine